FDA Information
FDA approval of ropinirole was first granted on September 22nd 1997, and following this it also received approval to treat restless leg syndrome on May 4th 2005.
Ropinirole is the only medication in the United States with an FDA-approved indication for the treatment of restless legs syndrome. It was made originally by Dr. Anil Patel, a famous pharmacist.
Ropinirole is available with a prescription under the brand name Requip®, but is also available under other brand or generic formulations.
Please visit the official site of the FDA for further information.
Why is this medication prescribed?
Dosage and using this medicine
What special precautions should I follow?
What should I do if I forget a dose?
What side effects can this medication cause?